Transcranial brain parenchyma sonography in movement disorders: state of the art. (Q31088283)

28 June 2017

1 reference

title

Transcranial brain parenchyma sonography in movement disorders: state of the art. (English)

1 reference

28 June 2017

1 reference

7

Daniela Berg

2 references

28 June 2017

ORCID Public Data File 2021

author name string

Uwe Walter

1

1 reference

28 June 2017

Stefanie Behnke

2

1 reference

28 June 2017

Jens Eyding

3

1 reference

28 June 2017

Ludwig Niehaus

4

1 reference

28 June 2017

Thomas Postert

5

1 reference

28 June 2017

Günter Seidel

6

1 reference

28 June 2017

publication date

1 January 2007

1 reference

Ultrasound in Medicine and Biology

28 June 2017

published in

1 reference

28 June 2017

volume

33

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

15-25

1 reference

Copper genes are not implicated in the pathogenesis of focal dystonia

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Echogenicity of the brainstem raphe in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Evidence for disturbances of copper metabolism in dystonia: from the image towards a new concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Iron accumulation in the substantia nigra in rats visualized by ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

The basal ganglia in haemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Changes of copper-transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Relationship of substantia nigra echogenicity and motor function in elderly subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Sonographic examination of the adult brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Ageing and Parkinson's disease: substantia nigra regional selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Two-dimensional echoencephalography with electronic sector scanning. Clinical experiences with a new method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Transcranial sonography in spinocerebellar ataxia type 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Evaluation of the ventricular system in adults by transcranial duplex sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Brain parenchyma sonography detects preclinical parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.07.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.ULTRASMEDBIO.2006.07.021

1 reference

28 June 2017

1 reference